Mixed options sentiment in Moderna (MRNA), with shares down $2.19 near $32.71. Options volume relatively light with 46k contracts traded and puts leading calls for a put/call ratio of 1.03, compared to a typical level near 0.65. Implied volatility (IV30) dropped 0.49 near 59.57,in the lowest 10% of observations over the past year, suggesting an expected daily move of $1.23. Put-call skew flattened, suggesting a modestly bullish tone.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNA:
- Vanguard S&P 500 ETF (VOO) Daily Update, 12/23/2025
- Exxon, Cisco, Moderna, Home Depot, McDonald’s Insider Shake-Up
- CEPI to fund Phase 3 trial for Moderna’s mRNA-1018 vaccine candidate
- Early notable gainers among liquid option names on December 17th
- Generation Bio price target lowered to $5.50 from $7 at Wedbush